Human Urinary Composition Controls Antibacterial Activity of Siderocalin. - Wikidata - wikimedia - TriplyDB

Human Urinary Composition Controls Antibacterial Activity of Siderocalin.

Human Urinary Composition Controls Antibacterial Activity of Siderocalin.

http://www.wikidata.org/entity/Q35783053

about

The Basics of Bacteriuria: Strategies of Microbes for Persistence in Urine Structural similarities of human and mammalian lipocalins, and their function in innate immunity and allergy Metabolic Adaptations of Uropathogenic E. coli in the Urinary Tract.Microbial Copper-binding Siderophores at the Host-Pathogen Interface Network Analysis Reveals Sex- and Antibiotic Resistance-Associated Antivirulence Targets in Clinical Uropathogens Siderophore biosynthesis coordinately modulated the virulence-associated interactive metabolome of uropathogenic Escherichia coli and human urine.Ferritinophagy drives uropathogenic Escherichia coli persistence in bladder epithelial cells Urinary Metabolomics Identifies a Molecular Correlate of Interstitial Cystitis/Bladder Pain Syndrome in a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Cohort.The Ligands of Neutrophil Gelatinase-Associated Lipocalin Transition Metals and Virulence in Bacteria.Human Metabolome-derived Cofactors Are Required for the Antibacterial Activity of Siderocalin in Urine.Siderophores in Iron Metabolism: From Mechanism to Therapy Potential.Metal homeostasis in infectious disease: recent advances in bacterial metallophores and the human metal-withholding response.Enterobacteria secrete an inhibitor of Pseudomonas virulence during clinical bacteriuria.Urine: Waste product or biologically active tissue?Modulation of urinary siderophores by the diet, gut microbiota and inflammation in mice.Lipocalin-2 derived from adipose tissue mediates aldosterone-induced renal injury

P2860

Q26767235-BD252C90-E9E4-4B7E-B61D-DCED30913E8B Q26779731-AADC1EAD-77C2-4163-855A-DD6E1AAD4528 Q33776967-8E0FF9B7-A526-489B-9615-D0ED741DA001 Q35905311-1C53B393-0A12-41C2-80C5-224CD38D086F Q36677371-0D98F466-B598-42B0-B387-6600A20A4D8B Q36796388-672A9EAD-7DE5-4C58-8459-4ABE8DB0B1BB Q36862645-9E1C08AE-FE1C-409E-993A-CFD4383219B8 Q37008508-6EE4AC88-F31A-4B0C-B67D-349CD007D815 Q37238644-205CB99E-A1BA-4B69-AA77-A63952A46782 Q37446682-7C7159AA-B33F-4672-A020-59462B905C6A Q37551280-AC03092C-4C59-4200-98C2-24A1D16B121C Q39003164-BE10C10F-3BA2-425A-A1C4-B893A7038BCE Q39043309-129FF53E-7ED7-4DCC-8942-6F42A09900D1 Q41355584-1E624470-B996-45DD-80BF-979CE4A14BBB Q49719924-FB3D43DD-2E31-49CA-8F4E-88AC46046F68 Q49958535-92DB45A2-F90E-47C3-825B-AA77DC728A32 Q58760700-E826B620-F582-401C-B3AC-D669198D1F1B

P2860

Human Urinary Composition Controls Antibacterial Activity of Siderocalin.

http://www.wikidata.org/entity/Q35783053

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Human Urinary Composition Controls Antibacterial Activity of Siderocalin.

@ast

Human Urinary Composition Controls Antibacterial Activity of Siderocalin.

@en

type

label

Human Urinary Composition Controls Antibacterial Activity of Siderocalin.

@ast

Human Urinary Composition Controls Antibacterial Activity of Siderocalin.

@en

prefLabel

Human Urinary Composition Controls Antibacterial Activity of Siderocalin.

@ast

Human Urinary Composition Controls Antibacterial Activity of Siderocalin.

@en

P1433

Q35783053-F568A01E-14AF-4897-A023-382F5624920D

P1476

Q35783053-55B627C0-0E21-48BC-8728-F6FDD5877A08

P2093

Q35783053-0F1C7532-0C6B-42F1-A0D0-0C81CFEBAFE0

Q35783053-3AA89B0D-69F5-459C-A6DF-7617E39055E1

Q35783053-592A39AA-1BD9-4D31-A927-C40A7C4E7968

Q35783053-BD376BC2-B076-4D43-A223-A2E72A9B30A0

Q35783053-D75D7FA4-749C-42AE-91D3-52E13808CEC0

Q35783053-DEC01CA8-7D98-4ACC-9D56-6D846282377F

Q35783053-E20CB12A-7882-49C0-BC47-218010F20619

P2860

Q35783053-01AAEE8C-D7B0-4A24-A923-6D9B93355EA4

Q35783053-01B3A356-A61A-4062-A51D-97C1B70C58B7

Q35783053-08439C8F-F530-4BC3-AB94-12286FE3732D

Q35783053-0C659B7B-4172-4521-8148-2FD9C67FE8E6

Q35783053-0CF5E343-F26B-46A2-8A60-9049A914398B

Q35783053-131FD3F5-70D9-4565-A797-25E4D74FAA44

Q35783053-158F40F9-B4C8-4700-9E1A-7FE4C98454A7

Q35783053-175D6E9C-52D5-4170-B046-685CF491CE31

Q35783053-1D420F12-FC52-4D81-84E9-3C314949EE20

Q35783053-203E8874-6DE1-42AD-9D1D-304CB2DB7154

P304

Q35783053-553A0D86-B01A-4BD2-9580-1BFF63038328

P31

Q35783053-E9A1035C-8CB8-49C2-9C6C-DFD0A0A6B3E3

P356

Q35783053-01A8A5FC-34CC-4131-A674-D2CDE126FE0D

P407

Q35783053-6897C868-1EAA-4498-ADDD-14F6EC01F531

P433

Q35783053-FA3D78ED-2DC6-4021-84B1-62B5AF5AFCFC

P478

Q35783053-CD523872-194E-4DDB-81EB-124CCCCF8021

P577

Q35783053-377442DF-91A2-4478-B5B3-18B8FFABFDC0

P698

Q35783053-29E0745B-703F-4414-B1D7-3AD6D33D2BA7

P932

Q35783053-19FC44D8-8D69-4371-B13B-C5851C66B8A5

P356

JBC.M115.645812

P1433

Journal of Biological Chemistry

P1476

Human Urinary Composition Controls Antibacterial Activity of Siderocalin.

@en

P2093

Ann E Stapleton

http://www.w3.org/2001/XMLSchema#string

Chia S Hung

http://www.w3.org/2001/XMLSchema#string

Courtney C Aldrich

http://www.w3.org/2001/XMLSchema#string

Jan R Crowley

http://www.w3.org/2001/XMLSchema#string

Jeffrey P Henderson

http://www.w3.org/2001/XMLSchema#string

Jonas Marschall

http://www.w3.org/2001/XMLSchema#string

Robin R Shields-Cutler

http://www.w3.org/2001/XMLSchema#string

P2860

Matplotlib: A 2D Graphics Environment

The human urine metabolome

Siderophore-based iron acquisition and pathogen control

Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli

The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition

Iron traffics in circulation bound to a siderocalin (Ngal)–catechol complex

One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products

Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli

Identification of sulfation sites of metabolites and prediction of the compounds' biological effects.

Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled.

P304

15949-15960

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M115.645812

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

290

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25861985

http://www.w3.org/2001/XMLSchema#string

P932

4481200

http://www.w3.org/2001/XMLSchema#string